Bank of America
RCEL icon

Bank of America’s Avita Medical RCEL Stock Holding History

Bank of America’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Sell
51,667
-10,461
-17% -$45.1K ﹤0.01% 5362
2026
Q1 		$230K Buy
62,128
+36,799
+145% +$155K ﹤0.01% 5291
2025
Q4 		$87.4K Sell
25,329
-36,810
-59% -$147K ﹤0.01% 5666
2025
Q3 		$318K Sell
62,139
-412
-0.7% -$2.15K ﹤0.01% 6050
2025
Q2 		$331K Buy
62,551
+20,767
+50% +$151K ﹤0.01% 5935
2025
Q1 		$340K Buy
41,784
+3,663
+10% +$34.2K ﹤0.01% 5870
2024
Q4 		$488K Buy
38,121
+5,324
+16% +$62.8K ﹤0.01% 5551
2024
Q3 		$352K Sell
32,797
-8,204
-20% -$77.1K ﹤0.01% 5708
2024
Q2 		$325K Buy
41,001
+10,680
+35% +$102K ﹤0.01% 5615
2024
Q1 		$486K Sell
30,321
-7,950
-21% -$129K ﹤0.01% 5364
2023
Q4 		$525K Sell
38,271
-22,455
-37% -$257K ﹤0.01% 5461
2023
Q3 		$887K Sell
60,726
-11,096
-15% -$188K ﹤0.01% 4897
2023
Q2 		$1.22M Buy
71,822
+34,736
+94% +$510K ﹤0.01% 4619
2023
Q1 		$518K Buy
37,086
+29,019
+360% +$309K ﹤0.01% 5357
2022
Q4 		$53.2K Buy
8,067
+2,336
+41% +$14K ﹤0.01% 6458
2022
Q3 		$30K Buy
5,731
+2,223
+63% +$13.7K ﹤0.01% 6877
2022
Q2 		$17K Sell
3,508
-5,076
-59% -$31.4K ﹤0.01% 7229
2022
Q1 		$72K Sell
8,584
-74,188
-90% -$684K ﹤0.01% 7017
2021
Q4 		$992K Buy
82,772
+52,961
+178% +$808K ﹤0.01% 5262
2021
Q3 		$528K Sell
29,811
-9,576
-24% -$181K ﹤0.01% 5606
2021
Q2 		$808K Buy
39,387
+4,905
+14% +$96.7K ﹤0.01% 5063
2021
Q1 		$683K Buy
34,482
+32,323
+1,497% +$752K ﹤0.01% 5139
2020
Q4 		$40K Sell
2,159
-141
-6% -$3.09K ﹤0.01% 6403
2020
Q3 		$58K Buy
2,300
+79
+4% +$1.97K ﹤0.01% 5958
2020
Q2 		$68K Buy
2,221
+832
+60% +$25.4K ﹤0.01% 5845
2020
Q1 		$43K Buy
1,389
+122
+10% +$5.05K ﹤0.01% 5928
2019
Q4 		$58K Buy
+1,267
New +$52.6K ﹤0.01% 6215

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America's RCEL Position: Q2 2026 in Review

Bank of America reduced its Avita Medical (RCEL) stake by 17% in Q2 2026, selling an estimated $45.1K and leaving 51,667 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #5362.

Bank of America first reported a position in RCEL in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.22M in Q2 2023. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Bank of America held 51,667 shares of Avita Medical worth $213K as of Q2 2026.
  • Bank of America sold 10,461 Avita Medical shares in Q2 2026, an estimated $45.1K.
  • Avita Medical made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #5362 holding.
  • Bank of America first reported a position in Avita Medical in Q4 2019 and has held it in 27 quarters since.
  • Bank of America's Avita Medical position peaked at $1.22M in Q2 2023.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.